240 related articles for article (PubMed ID: 24630270)
21. Switching to Glycerol Phenylbutyrate in 48 Patients with Urea Cycle Disorders: Clinical Experience in Spain.
Martín-Hernández E; Quijada-Fraile P; Correcher P; Meavilla S; Sánchez-Pintos P; de Las Heras Montero J; Blasco-Alonso J; Dougherty L; Marquez A; Peña-Quintana L; Cañedo E; García-Jimenez MC; Moreno Lozano PJ; Murray Hurtado M; Camprodon Gómez M; Barrio-Carreras D; de Los Santos M; Del Toro M; Couce ML; Vitoria Miñana I; Morales Conejo M; Bellusci M
J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078975
[TBL] [Abstract][Full Text] [Related]
22. Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.
Rockey DC; Vierling JM; Mantry P; Ghabril M; Brown RS; Alexeeva O; Zupanets IA; Grinevich V; Baranovsky A; Dudar L; Fadieienko G; Kharchenko N; Klaryts'ka I; Morozov V; Grewal P; McCashland T; Reddy KG; Reddy KR; Syplyviy V; Bass NM; Dickinson K; Norris C; Coakley D; Mokhtarani M; Scharschmidt BF;
Hepatology; 2014 Mar; 59(3):1073-83. PubMed ID: 23847109
[TBL] [Abstract][Full Text] [Related]
23. Direct replacement of oral sodium benzoate with glycerol phenylbutyrate in children with urea cycle disorders.
Yeo M; Rehsi P; Dorman M; Grunewald S; Baruteau J; Chakrapani A; Footitt E; Prunty H; McSweeney M
JIMD Rep; 2022 Mar; 63(2):137-145. PubMed ID: 35281661
[TBL] [Abstract][Full Text] [Related]
24. Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels.
Jiang Y; Almannai M; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2017 Nov; 122(3):39-45. PubMed ID: 28888854
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial to examine the impact of food on pharmacokinetics of 4-phenylbutyrate and change in amino acid availability after a single oral administration of sodium 4-phenylbutyrarte in healthy volunteers.
Osaka S; Nakano S; Mizuno T; Hiraoka Y; Minowa K; Hirai S; Mizutani A; Sabu Y; Miura Y; Shimizu T; Kusuhara H; Suzuki M; Hayashi H
Mol Genet Metab; 2021 Apr; 132(4):220-226. PubMed ID: 33648834
[TBL] [Abstract][Full Text] [Related]
26. Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder.
Lee B; Diaz GA; Rhead W; Lichter-Konecki U; Feigenbaum A; Berry SA; Le Mons C; Bartley JA; Longo N; Nagamani SC; Berquist W; Gallagher R; Bartholomew D; Harding CO; Korson MS; McCandless SE; Smith W; Cederbaum S; Wong D; Merritt JL; Schulze A; Vockley J; Kronn D; Zori R; Summar M; Milikien DA; Marino M; Coakley DF; Mokhtarani M; ; Scharschmidt BF
Genet Med; 2015 Jul; 17(7):561-8. PubMed ID: 25503497
[TBL] [Abstract][Full Text] [Related]
27. Protein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate.
Hook D; Diaz GA; Lee B; Bartley J; Longo N; Berquist W; Le Mons C; Rudolph-Angelich I; Porter M; Scharschmidt BF; Mokhtarani M
Mol Genet Metab Rep; 2016 Mar; 6():34-40. PubMed ID: 27014577
[TBL] [Abstract][Full Text] [Related]
28. [Preliminary study of glyceryl phenylbutyrate therapy for Ornithine transcarbamylase deficiency and a literature review].
Zhou D; Shang X; Qiao Y; Cheng Y; Yu Z; Huang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Sep; 40(9):1107-1112. PubMed ID: 37643956
[TBL] [Abstract][Full Text] [Related]
29. An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease.
De Las Heras J; Aldámiz-Echevarría L; Martínez-Chantar ML; Delgado TC
Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):439-448. PubMed ID: 27860485
[TBL] [Abstract][Full Text] [Related]
30. The burden of pharmacological treatment on health-related quality of life in people with a urea cycle disorder: a qualitative study.
Yeowell G; Burns DS; Fatoye F
J Patient Rep Outcomes; 2021 Oct; 5(1):110. PubMed ID: 34694515
[TBL] [Abstract][Full Text] [Related]
31. Glycerol phenylbutyrate for the chronic management of urea cycle disorders.
Oishi K; Diaz GA
Expert Rev Endocrinol Metab; 2014 Sep; 9(5):427-434. PubMed ID: 30736206
[TBL] [Abstract][Full Text] [Related]
32. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
Scaglia F; Carter S; O'Brien WE; Lee B
Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
[TBL] [Abstract][Full Text] [Related]
33. Results from a Nationwide Cohort Temporary Utilization Authorization (ATU) survey of patients in france treated with Pheburane(®) (Sodium Phenylbutyrate) taste-masked granules.
Kibleur Y; Dobbelaere D; Barth M; Brassier A; Guffon N
Paediatr Drugs; 2014 Oct; 16(5):407-15. PubMed ID: 24962711
[TBL] [Abstract][Full Text] [Related]
34. Quantification of urinary derivatives of Phenylbutyric and Benzoic acids by LC-MS/MS as treatment compliance biomarkers in Urea Cycle disorders.
Andrade F; Vitoria I; Martín Hernández E; Pintos-Morell G; Correcher P; Puig-Piña R; Quijada-Fraile P; Peña-Quintana L; Marquez AM; Villate O; García Silva MT; de Las Heras J; Ceberio L; Rodrigues E; Almeida Campos T; Yahyaoui R; Blasco J; Vives-Piñera I; Gil D; Del Toro M; Ruiz-Pons M; Cañedo E; Barba Romero MA; García-Jiménez MC; Aldámiz-Echevarría L
J Pharm Biomed Anal; 2019 Nov; 176():112798. PubMed ID: 31394303
[TBL] [Abstract][Full Text] [Related]
35. Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.
Marini JC; Lanpher BC; Scaglia F; O'Brien WE; Sun Q; Garlick PJ; Jahoor F; Lee B
Am J Clin Nutr; 2011 Jun; 93(6):1248-54. PubMed ID: 21490144
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Follow-Up on a Cohort Temporary Utilization Authorization (ATU) Survey of Patients Treated with Pheburane (Sodium Phenylbutyrate) Taste-Masked Granules.
Kibleur Y; Guffon N
Paediatr Drugs; 2016 Apr; 18(2):139-44. PubMed ID: 26747635
[TBL] [Abstract][Full Text] [Related]
37. New insights in nutritional management and amino acid supplementation in urea cycle disorders.
Scaglia F
Mol Genet Metab; 2010; 100 Suppl 1(Suppl 1):S72-6. PubMed ID: 20299258
[TBL] [Abstract][Full Text] [Related]
38. Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients.
Burlina AB; Ogier H; Korall H; Trefz FK
Mol Genet Metab; 2001 Apr; 72(4):351-5. PubMed ID: 11286510
[TBL] [Abstract][Full Text] [Related]
39. Glycerol Phenylbutyrate in Patients With Cirrhosis and Episodic Hepatic Encephalopathy: A Pilot Study of Safety and Effect on Venous Ammonia Concentration.
Ghabril M; Zupanets IA; Vierling J; Mantry P; Rockey D; Wolf D; O'Shea R; Dickinson K; Gillaspy H; Norris C; Coakley DF; Mokhtarani M; Scharschmidt BF
Clin Pharmacol Drug Dev; 2013 Jul; 2(3):278-84. PubMed ID: 27121790
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
